Frederick Hausheer Selected Research

gamma-methylene-10-deazaaminopterin

5/2004

Final results of a phase I and pharmacokinetic study of gamma-methylene-10-deazaaminopterin (MDAM) administered intravenously daily for five consecutive days in patients with solid tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Frederick Hausheer Research Topics

Disease

2	Neoplasms (Cancer) 07/2014 - 05/2004
1	Colonic Neoplasms (Colon Cancer) 07/2014
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2011
1	Neoplasm Metastasis (Metastasis) 04/2005
1	Melanoma (Melanoma, Malignant) 04/2005

Drug/Important Bio-Agent (IBA)

1	DNA (Deoxyribonucleic Acid)IBA 07/2014
1	Pharmaceutical PreparationsIBA 07/2014
1	MethyltransferasesIBA 07/2014
1	2,2'-dithiodiethanesulfonic acid (dimesna)IBA 03/2011
1	Cisplatin (Platino)FDA LinkGeneric 03/2011
1	Paclitaxel (Taxol)FDA LinkGeneric 03/2011
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 04/2005
1	cositecanIBA 04/2005
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 04/2005
1	CamptothecinIBA 04/2005
1	Folic Acid AntagonistsIBA 05/2004
1	Methotrexate (Mexate)FDA LinkGeneric 05/2004
1	gamma-methylene-10-deazaaminopterinIBA 05/2004

Therapy/Procedure

1	Therapeutics 07/2014
1	Drug Therapy (Chemotherapy) 04/2005
1	Immunotherapy 04/2005